Subsequently, real-time quantitative PCR, or FISH and flow cytometry lymphocyte phenotyping, were performed in assessing FIP1L1-PDGFRA gene fusion, rare mutations and rearrangements, and clonal or aberrant T-cell populations in order to exclude clonal bone marrow disease [21]. This evidence concerns the gene FIP1L1 and bone marrow disorder.